应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
TOVX Theriva Biologics
休市中 07-18 16:00:00 EDT
0.4830
+0.0060
+1.26%
盘后
0.4827
-0.0003
-0.06%
19:47 EDT
最高
0.5000
最低
0.4770
成交量
10.79万
今开
0.4800
昨收
0.4770
日振幅
4.82%
总市值
437.56万
流通市值
436.93万
总股本
905.92万
成交额
5.23万
换手率
1.19%
流通股本
904.62万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Theriva Biologics, Inc.盘中异动 股价大涨7.30%报0.500美元
市场透视 · 07-17 14:18
Theriva Biologics, Inc.盘中异动 股价大涨7.30%报0.500美元
Theriva Biologics, Inc.盘中异动 大幅跳水5.43%报0.470美元
市场透视 · 07-15
Theriva Biologics, Inc.盘中异动 大幅跳水5.43%报0.470美元
Theriva Biologics, Inc.盘中异动 快速拉升5.06%报0.494美元
市场透视 · 07-11
Theriva Biologics, Inc.盘中异动 快速拉升5.06%报0.494美元
Theriva Biologics, Inc.盘中异动 早盘快速拉升5.53%报0.454美元
市场透视 · 07-08
Theriva Biologics, Inc.盘中异动 早盘快速拉升5.53%报0.454美元
Theriva Biologics, Inc.盘中异动 早盘快速拉升7.93%
市场透视 · 06-26
Theriva Biologics, Inc.盘中异动 早盘快速拉升7.93%
Theriva Biologics, Inc.盘中异动 大幅跳水5.04%报0.456美元
市场透视 · 06-16
Theriva Biologics, Inc.盘中异动 大幅跳水5.04%报0.456美元
Theriva Biologics, Inc.盘中异动 临近收盘股价大跌5.92%报0.470美元
市场透视 · 06-13
Theriva Biologics, Inc.盘中异动 临近收盘股价大跌5.92%报0.470美元
Theriva Biologics, Inc.盘中异动 大幅拉升5.05%报0.520美元
市场透视 · 06-11
Theriva Biologics, Inc.盘中异动 大幅拉升5.05%报0.520美元
Theriva Biologics, Inc.盘中异动 早盘股价大涨5.11%
市场透视 · 06-10
Theriva Biologics, Inc.盘中异动 早盘股价大涨5.11%
Theriva Biologics, Inc.盘中异动 快速下挫7.11%报0.437美元
市场透视 · 06-04
Theriva Biologics, Inc.盘中异动 快速下挫7.11%报0.437美元
Theriva Biologics, Inc.盘中异动 股价大涨9.15%报0.533美元
市场透视 · 06-03
Theriva Biologics, Inc.盘中异动 股价大涨9.15%报0.533美元
Theriva Biologics, Inc.盘中异动 下午盘急速上涨5.12%报0.450美元
市场透视 · 05-29
Theriva Biologics, Inc.盘中异动 下午盘急速上涨5.12%报0.450美元
Theriva Biologics, Inc.盘中异动 股价大跌5.49%报0.430美元
市场透视 · 05-27
Theriva Biologics, Inc.盘中异动 股价大跌5.49%报0.430美元
Theriva Biologics, Inc.2025财年第一财季实现净利润-4.32百万美元,同比增加16.44%
市场透视 · 05-22
Theriva Biologics, Inc.2025财年第一财季实现净利润-4.32百万美元,同比增加16.44%
Theriva Biologics, Inc.盘中异动 股价大跌8.61%
市场透视 · 05-22
Theriva Biologics, Inc.盘中异动 股价大跌8.61%
Theriva Biologics, Inc.盘中异动 快速跳水5.05%
市场透视 · 05-20
Theriva Biologics, Inc.盘中异动 快速跳水5.05%
Theriva Biologics, Inc.盘中异动 早盘股价大跌5.03%
市场透视 · 05-19
Theriva Biologics, Inc.盘中异动 早盘股价大跌5.03%
Theriva Biologics, Inc.盘中异动 早盘股价大跌5.38%报0.537美元
市场透视 · 05-15
Theriva Biologics, Inc.盘中异动 早盘股价大跌5.38%报0.537美元
Theriva Biologics, Inc.盘中异动 早盘急速拉升5.04%
市场透视 · 05-14
Theriva Biologics, Inc.盘中异动 早盘急速拉升5.04%
Theriva Biologics:2025年Q1财报实现营收0美元,前值为0美元;每股收益为-1.55美元,前值为-7.53美元。
金融界 · 05-14
Theriva Biologics:2025年Q1财报实现营收0美元,前值为0美元;每股收益为-1.55美元,前值为-7.53美元。
加载更多
公司概况
公司名称:
Theriva Biologics
所属市场:
AMEX
上市日期:
--
主营业务:
Theriva Biologics, Inc.成立于1986年,是一家生物技术公司,专注于合成DNA为基础的疗法和治疗严重疾病的创新型疾病缓解药物的发展。该公司是一家多元化的临床阶段公司,开发旨在治疗高度未满足需求领域疾病的疗法。公司通过收购VCN Biosciences,SL进入肿瘤学领域,VCN Biosciences,SL开发了一种新的溶瘤腺病毒平台,设计用于静脉、玻璃体内和抗肿瘤递送以触发肿瘤细胞死亡,改善共同给药的癌症疗法对肿瘤的获取,并促进患者免疫系统产生强大而持续的抗肿瘤反应。
发行价格:
--
{"stockData":{"symbol":"TOVX","market":"US","secType":"STK","nameCN":"Theriva Biologics","latestPrice":0.483,"timestamp":1752868800000,"preClose":0.477,"halted":0,"volume":107906,"hourTrading":{"tag":"盘后","latestPrice":0.4827,"preClose":0.483,"latestTime":"19:47 EDT","volume":4116,"amount":1999.5776,"timestamp":1752882460316},"delay":0,"floatShares":9046200,"shares":9059241,"eps":-19.028637,"marketStatus":"休市中","change":0.006,"latestTime":"07-18 16:00:00 EDT","open":0.48,"high":0.5,"low":0.477,"amount":52263.86537344,"amplitude":0.048218,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-19.028637,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1753084800000},"marketStatusCode":7,"adr":0,"exchange":"AMEX","adjPreClose":0.477,"preHourTrading":{"tag":"盘前","latestPrice":0.4821,"preClose":0.4848,"latestTime":"08:39 EDT","volume":6507,"amount":3178.84148001,"timestamp":1752842377548},"postHourTrading":{"tag":"盘后","latestPrice":0.4827,"preClose":0.483,"latestTime":"19:47 EDT","volume":4116,"amount":1999.5776,"timestamp":1752882460316},"volumeRatio":0.46996351753620264},"requestUrl":"/m/hq/s/TOVX","defaultTab":"news","newsList":[{"id":"2552654487","title":"Theriva Biologics, Inc.盘中异动 股价大涨7.30%报0.500美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552654487","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552654487?lang=zh_cn&edition=full","pubTime":"2025-07-17 22:18","pubTimestamp":1752761937,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日22时18分,Theriva Biologics, Inc.股票出现异动,股价急速拉升7.30%。截至发稿,该股报0.500美元/股,成交量8.6837万股,换手率0.96%,振幅8.37%。Theriva Biologics, Inc.股票所在的生物技术行业中,整体涨幅为0.28%。Theriva Biologics, Inc.公司简介:Theriva Biologics Inc是一家临床阶段的制药公司,开发一种新的溶瘤腺病毒平台,以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071722185797a9e0c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071722185797a9e0c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2551957751","title":"Theriva Biologics, Inc.盘中异动 大幅跳水5.43%报0.470美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551957751","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551957751?lang=zh_cn&edition=full","pubTime":"2025-07-15 23:41","pubTimestamp":1752594117,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日23时41分,Theriva Biologics, Inc.股票出现波动,股价大幅下挫5.43%。Theriva Biologics, Inc.股票所在的生物技术行业中,整体跌幅为0.30%。其相关个股中,Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大,Polyrizon Ltd.、Cyclacel Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃,换手率分别为1858.06%、1700.31%、1524.63%,振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、Polyrizon Ltd.,振幅分别为416.92%、109.47%、75.50%。Theriva Biologics, Inc.公司简介:Theriva Biologics Inc是一家临床阶段的制药公司,开发一种新的溶瘤腺病毒平台,以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071523415897a73a09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071523415897a73a09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2550702968","title":"Theriva Biologics, Inc.盘中异动 快速拉升5.06%报0.494美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550702968","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550702968?lang=zh_cn&edition=full","pubTime":"2025-07-12 00:59","pubTimestamp":1752253155,"startTime":"0","endTime":"0","summary":"北京时间2025年07月12日00时59分,Theriva Biologics, Inc.股票出现波动,股价急速上涨5.06%。截至发稿,该股报0.494美元/股,成交量19.6624万股,换手率2.17%,振幅5.66%。Theriva Biologics, Inc.股票所在的生物技术行业中,整体跌幅为0.33%。Theriva Biologics, Inc.公司简介:Theriva Biologics Inc是一家临床阶段的制药公司,开发一种新的溶瘤腺病毒平台,以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712005915a6a43fe4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712005915a6a43fe4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2549232845","title":"Theriva Biologics, Inc.盘中异动 早盘快速拉升5.53%报0.454美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549232845","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549232845?lang=zh_cn&edition=full","pubTime":"2025-07-08 21:57","pubTimestamp":1751983059,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日21时57分,Theriva Biologics, Inc.股票出现波动,股价快速上涨5.53%。Theriva Biologics, Inc.股票所在的生物技术行业中,整体涨幅为0.74%。其相关个股中,Prokidney Corp.、Rallybio Corporation、Moleculin Biotech, Inc.涨幅较大,Zyversa Therapeutics, Inc.、Rallybio Corporation、Plus Therapeutics, Inc.较为活跃,换手率分别为842.49%、216.46%、146.27%,振幅较大的相关个股有Moleculin Biotech, Inc.、Prokidney Corp.、Rallybio Corporation,振幅分别为69.44%、62.64%、59.87%。Theriva Biologics, Inc.公司简介:Theriva Biologics Inc是一家临床阶段的制药公司,开发一种新的溶瘤腺病毒平台,以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708215739953aeb25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708215739953aeb25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2546736025","title":"Theriva Biologics, Inc.盘中异动 早盘快速拉升7.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546736025","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546736025?lang=zh_cn&edition=full","pubTime":"2025-06-26 21:34","pubTimestamp":1750944882,"startTime":"0","endTime":"0","summary":"北京时间2025年06月26日21时34分,Theriva Biologics, Inc.股票出现异动,股价急速上涨7.93%。Theriva Biologics, Inc.股票所在的生物技术行业中,整体跌幅为0.15%。其相关个股中,Vor Biopharma Inc.、Adial Pharmaceuticals, Inc、Plus Therapeutics, Inc.涨幅较大,Adial Pharmaceuticals, Inc、Plus Therapeutics, Inc.、Aspire Biopharma Holdings, Inc.较为活跃,换手率分别为789.45%、183.34%、67.19%,振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Vor Biopharma Inc.、Plus Therapeutics, Inc.,振幅分别为40.05%、36.06%、14.51%。Theriva Biologics, Inc.公司简介:Theriva Biologics Inc是一家临床阶段的制药公司,开发一种新的溶瘤腺病毒平台,以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626213442a4bf4b0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626213442a4bf4b0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2543360300","title":"Theriva Biologics, Inc.盘中异动 大幅跳水5.04%报0.456美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543360300","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543360300?lang=zh_cn&edition=full","pubTime":"2025-06-16 22:02","pubTimestamp":1750082548,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日22时02分,Theriva Biologics, Inc.股票出现波动,股价急速跳水5.04%。Theriva Biologics, Inc.股票所在的生物技术行业中,整体跌幅为0.12%。其相关个股中,Sage Therapeutics, Inc.、Matinas Biopharma Holdings, Inc.、Immuneering Corporation涨幅较大,Nucana Plc、Processa Pharmaceuticals, Inc.、Pmgc Holdings Inc.较为活跃,换手率分别为1669.33%、190.68%、37.67%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Nextcure, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 ,振幅分别为58.78%、32.11%、30.36%。Theriva Biologics, Inc.公司简介:Theriva Biologics Inc是一家临床阶段的制药公司,开发一种新的溶瘤腺病毒平台,以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616220229a4ac412a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616220229a4ac412a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2543007632","title":"Theriva Biologics, Inc.盘中异动 临近收盘股价大跌5.92%报0.470美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543007632","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543007632?lang=zh_cn&edition=full","pubTime":"2025-06-14 03:30","pubTimestamp":1749843025,"startTime":"0","endTime":"0","summary":"北京时间2025年06月14日03时30分,Theriva Biologics, Inc.股票出现波动,股价急速下跌5.92%。截至发稿,该股报0.470美元/股,成交量10.8886万股,换手率1.33%,振幅5.90%。Theriva Biologics, Inc.股票所在的生物技术行业中,整体跌幅为0.58%。Theriva Biologics, Inc.公司简介:Theriva Biologics Inc是一家临床阶段的制药公司,开发一种新的溶瘤腺病毒平台,以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614033025a7081f3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614033025a7081f3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2542726539","title":"Theriva Biologics, Inc.盘中异动 大幅拉升5.05%报0.520美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542726539","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542726539?lang=zh_cn&edition=full","pubTime":"2025-06-12 00:50","pubTimestamp":1749660643,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日00时50分,Theriva Biologics, Inc.股票出现波动,股价快速上涨5.05%。截至发稿,该股报0.520美元/股,成交量23.5875万股,换手率2.88%,振幅8.38%。Theriva Biologics, Inc.股票所在的生物技术行业中,整体涨幅为0.49%。Theriva Biologics, Inc.公司简介:Theriva Biologics Inc是一家临床阶段的制药公司,开发一种新的溶瘤腺病毒平台,以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612005043a4a3c72f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612005043a4a3c72f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2542434403","title":"Theriva Biologics, Inc.盘中异动 早盘股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542434403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542434403?lang=zh_cn&edition=full","pubTime":"2025-06-10 22:39","pubTimestamp":1749566377,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日22时39分,Theriva Biologics, Inc.股票出现波动,股价急速拉升5.11%。Theriva Biologics, Inc.股票所在的生物技术行业中,整体涨幅为0.69%。其相关个股中,Carisma Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nucana Plc涨幅较大,Nucana Plc、Windtree Therapeutics, Inc.、Evogene Ltd.较为活跃,换手率分别为22008.15%、2468.23%、1127.43%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Carisma Therapeutics, Inc.、Nucana Plc,振幅分别为253.85%、191.40%、99.74%。Theriva Biologics, Inc.公司简介:Theriva Biologics Inc是一家临床阶段的制药公司,开发一种新的溶瘤腺病毒平台,以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506102239379779873f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506102239379779873f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2540061623","title":"Theriva Biologics, Inc.盘中异动 快速下挫7.11%报0.437美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540061623","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540061623?lang=zh_cn&edition=full","pubTime":"2025-06-04 21:32","pubTimestamp":1749043940,"startTime":"0","endTime":"0","summary":"北京时间2025年06月04日21时32分,Theriva Biologics, Inc.股票出现异动,股价快速下跌7.11%。Theriva Biologics, Inc.股票所在的生物技术行业中,整体涨幅为0.35%。其相关个股中,Cellectar Biosciences, Inc.、知临集团、再鼎医药涨幅较大,Nucana Plc、Conduit Pharmaceuticals Inc.、Cellectar Biosciences, Inc.较为活跃,换手率分别为505.65%、494.18%、259.23%,振幅较大的相关个股有Cellectar Biosciences, Inc.、知临集团、Processa Pharmaceuticals, Inc.,振幅分别为17.07%、15.45%、10.68%。Theriva Biologics, Inc.公司简介:Theriva Biologics Inc是一家临床阶段的制药公司,开发一种新的溶瘤腺病毒平台,以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604213220a499fbd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604213220a499fbd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2540777310","title":"Theriva Biologics, Inc.盘中异动 股价大涨9.15%报0.533美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540777310","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540777310?lang=zh_cn&edition=full","pubTime":"2025-06-03 21:30","pubTimestamp":1748957403,"startTime":"0","endTime":"0","summary":"北京时间2025年06月03日21时30分,Theriva Biologics, Inc.股票出现异动,股价快速拉升9.15%。Theriva Biologics, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Zymeworks Inc.、Zyversa Therapeutics, Inc.、Zevra Therapeutics, Inc.涨幅较大,Revelation Biosciences, Inc.、Traws Pharma, Inc.、Kiora Pharmaceuticals, Inc.较为活跃,换手率分别为3346.42%、772.52%、627.11%,振幅较大的相关个股有Zymeworks Inc.、Zyversa Therapeutics, Inc.、Zevra Therapeutics, Inc.,振幅分别为0.00%、0.00%、0.00%。Theriva Biologics, Inc.公司简介:Theriva Biologics Inc是一家临床阶段的制药公司,开发一种新的溶瘤腺病毒平台,以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603213003a6f8bbcd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603213003a6f8bbcd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2539298020","title":"Theriva Biologics, Inc.盘中异动 下午盘急速上涨5.12%报0.450美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539298020","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539298020?lang=zh_cn&edition=full","pubTime":"2025-05-30 02:55","pubTimestamp":1748544903,"startTime":"0","endTime":"0","summary":"北京时间2025年05月30日02时55分,Theriva Biologics, Inc.股票出现波动,股价急速拉升5.12%。截至发稿,该股报0.450美元/股,成交量24.9184万股,换手率3.04%,振幅8.01%。Theriva Biologics, Inc.股票所在的生物技术行业中,整体涨幅为1.32%。Theriva Biologics, Inc.公司简介:Theriva Biologics Inc是一家临床阶段的制药公司,开发一种新的溶瘤腺病毒平台,以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530025503a6f239ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530025503a6f239ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2538467496","title":"Theriva Biologics, Inc.盘中异动 股价大跌5.49%报0.430美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538467496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538467496?lang=zh_cn&edition=full","pubTime":"2025-05-27 22:33","pubTimestamp":1748356402,"startTime":"0","endTime":"0","summary":"北京时间2025年05月27日22时33分,Theriva Biologics, Inc.股票出现异动,股价急速下挫5.49%。截至发稿,该股报0.430美元/股,成交量8.7219万股,换手率1.07%,振幅4.59%。Theriva Biologics, Inc.股票所在的生物技术行业中,整体涨幅为1.14%。Theriva Biologics, Inc.公司简介:Theriva Biologics Inc是一家临床阶段的制药公司,开发一种新的溶瘤腺病毒平台,以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527223323aa2c9a38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527223323aa2c9a38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2537925956","title":"Theriva Biologics, Inc.2025财年第一财季实现净利润-4.32百万美元,同比增加16.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537925956","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537925956?lang=zh_cn&edition=full","pubTime":"2025-05-23 00:00","pubTimestamp":1747929631,"startTime":"0","endTime":"0","summary":"5月23日,Theriva Biologics, Inc.公布财报,公告显示公司2025财年第一财季净利润为-4.32百万美元,同比增加16.44%;其中营业收入为0.00美元,每股基本收益为-1.55美元。从资产负债表来看,Theriva Biologics, Inc.总负债16.66百万美元,其中短期债务619000.00美元,资产负债比为1.94,流动比率为1.54。机构评级:截至2025年5月23日,当前有1家机构对Theriva Biologics, Inc.目标价做出预测,其中目标均价为7.00美元,其中最低目标价为7.00美元,最高目标价为7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000111a4887678&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000111a4887678&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX"],"gpt_icon":0},{"id":"2537625940","title":"Theriva Biologics, Inc.盘中异动 股价大跌8.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537625940","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537625940?lang=zh_cn&edition=full","pubTime":"2025-05-22 22:38","pubTimestamp":1747924703,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日22时38分,Theriva Biologics, Inc.股票出现异动,股价快速下跌8.61%。Theriva Biologics, Inc.股票所在的生物技术行业中,整体跌幅为0.57%。其相关个股中,Vigil Neuroscience, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Instil Bio, Inc.涨幅较大,Polyrizon Ltd.、Biodexa Pharmaceuticals Plc、Nucana Plc较为活跃,换手率分别为2205.26%、2166.17%、685.47%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Imunon, Inc.、Celularity Inc C/Wts 16/07/2026 ,振幅分别为64.32%、55.11%、46.38%。Theriva Biologics, Inc.公司简介:Theriva Biologics Inc是一家临床阶段的制药公司,开发一种新的溶瘤腺病毒平台,以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522223823a48863fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522223823a48863fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2536643226","title":"Theriva Biologics, Inc.盘中异动 快速跳水5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536643226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536643226?lang=zh_cn&edition=full","pubTime":"2025-05-20 21:52","pubTimestamp":1747749135,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日21时52分,Theriva Biologics, Inc.股票出现波动,股价大幅下挫5.05%。Theriva Biologics, Inc.股票所在的生物技术行业中,整体涨幅为0.18%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Neuraxis, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Polyrizon Ltd.、Eyenovia, Inc.、Neuraxis, Inc.较为活跃,换手率分别为1484.32%、1319.34%、722.59%,振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Psyence Biomedical Ltd C/Wts 25/01/2029、Neuraxis, Inc.,振幅分别为136.36%、95.65%、62.11%。Theriva Biologics, Inc.公司简介:Theriva Biologics Inc是一家临床阶段的制药公司,开发一种新的溶瘤腺病毒平台,以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520215215a6e6281f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520215215a6e6281f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2536512633","title":"Theriva Biologics, Inc.盘中异动 早盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536512633","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536512633?lang=zh_cn&edition=full","pubTime":"2025-05-19 22:36","pubTimestamp":1747665360,"startTime":"0","endTime":"0","summary":"北京时间2025年05月19日22时36分,Theriva Biologics, Inc.股票出现波动,股价快速跳水5.03%。Theriva Biologics, Inc.股票所在的生物技术行业中,整体跌幅为0.23%。其相关个股中,Protagenic Therapeutics Inc C/Wts 26/04/2026 、Protagenic Therapeutics, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 涨幅较大,Polyrizon Ltd.、Protagenic Therapeutics, Inc.、Nucana Plc较为活跃,换手率分别为8851.77%、6416.63%、2385.17%,振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Protagenic Therapeutics, Inc.、Brainstorm Cell Therapeutics Inc.,振幅分别为330.19%、87.13%、31.82%。Theriva Biologics, Inc.公司简介:Theriva Biologics Inc是一家临床阶段的制药公司,开发一种新的溶瘤腺病毒平台,以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051922360094fb9ec7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051922360094fb9ec7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2535827151","title":"Theriva Biologics, Inc.盘中异动 早盘股价大跌5.38%报0.537美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535827151","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535827151?lang=zh_cn&edition=full","pubTime":"2025-05-15 22:29","pubTimestamp":1747319341,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日22时29分,Theriva Biologics, Inc.股票出现波动,股价大幅跳水5.38%。截至发稿,该股报0.537美元/股,成交量14.3371万股,换手率5.15%,振幅8.48%。Theriva Biologics, Inc.股票所在的生物技术行业中,整体涨幅为0.43%。Theriva Biologics, Inc.公司简介:Theriva Biologics Inc是一家临床阶段的制药公司,开发一种新的溶瘤腺病毒平台,以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515222901a6e07b4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515222901a6e07b4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2535020136","title":"Theriva Biologics, Inc.盘中异动 早盘急速拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535020136","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535020136?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:41","pubTimestamp":1747230111,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日21时41分,Theriva Biologics, Inc.股票出现波动,股价大幅上涨5.04%。Theriva Biologics, Inc.股票所在的生物技术行业中,整体涨幅为0.30%。其相关个股中,Septerna, Inc.、蓝鸟生物、Nucana Plc涨幅较大,Nucana Plc、Polyrizon Ltd.、Pasithea Therapeutics Corp.较为活跃,换手率分别为2326.78%、1664.41%、321.77%,振幅较大的相关个股有Humacyte Inc C/Wts 27/08/2026 、Septerna, Inc.、Nucana Plc,振幅分别为46.33%、26.75%、23.40%。Theriva Biologics, Inc.公司简介:Theriva Biologics Inc是一家临床阶段的制药公司,开发一种新的溶瘤腺病毒平台,以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514214151a6df0ab6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514214151a6df0ab6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2535502713","title":"Theriva Biologics:2025年Q1财报实现营收0美元,前值为0美元;每股收益为-1.55美元,前值为-7.53美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535502713","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535502713?lang=zh_cn&edition=full","pubTime":"2025-05-14 20:58","pubTimestamp":1747227505,"startTime":"0","endTime":"0","summary":"Theriva Biologics(TOVX.US):2025年Q1财报实现营收0美元,前值为0美元;每股收益为-1.55美元,前值为-7.53美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051421005694f6c02b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051421005694f6c02b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.therivabio.com","stockEarnings":[{"period":"1week","weight":-0.0378},{"period":"1month","weight":0.071},{"period":"3month","weight":-0.6436},{"period":"6month","weight":-0.6736},{"period":"1year","weight":-0.9299},{"period":"ytd","weight":-0.724}],"compareEarnings":[{"period":"1week","weight":0.0064},{"period":"1month","weight":0.0504},{"period":"3month","weight":0.1922},{"period":"6month","weight":0.0502},{"period":"1year","weight":0.1356},{"period":"ytd","weight":0.0708}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Theriva Biologics, Inc.成立于1986年,是一家生物技术公司,专注于合成DNA为基础的疗法和治疗严重疾病的创新型疾病缓解药物的发展。该公司是一家多元化的临床阶段公司,开发旨在治疗高度未满足需求领域疾病的疗法。公司通过收购VCN Biosciences,SL进入肿瘤学领域,VCN Biosciences,SL开发了一种新的溶瘤腺病毒平台,设计用于静脉、玻璃体内和抗肿瘤递送以触发肿瘤细胞死亡,改善共同给药的癌症疗法对肿瘤的获取,并促进患者免疫系统产生强大而持续的抗肿瘤反应。","exchange":"AMEX","name":"Theriva Biologics","nameEN":"Theriva Biologics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Theriva Biologics(TOVX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Theriva Biologics(TOVX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Theriva Biologics,TOVX,Theriva Biologics股票,Theriva Biologics股票老虎,Theriva Biologics股票老虎国际,Theriva Biologics行情,Theriva Biologics股票行情,Theriva Biologics股价,Theriva Biologics股市,Theriva Biologics股票价格,Theriva Biologics股票交易,Theriva Biologics股票购买,Theriva Biologics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Theriva Biologics(TOVX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Theriva Biologics(TOVX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}